Epidermal growth factor receptor (EGFR)-directed PROTACs: mechanistic validation, mutant selectivity, and translational challenges

This is the authors' abstract. We don't add key points for this paper.

Proteolysis-targeting chimeras (PROTACs) have emerged as a promising strategy for targeted protein degradation (TPD), specifically for proteins previously considered difficult to drug [1]. Their...